LFWD · Lifeward Ltd. · Insider Trading

Represents 13,643 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 20, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments commencing from the Grant Date.

Represents 6,711 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 14, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments commencing from the Grant Date.

Represents 15,000 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on May 1, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing from the Grant Date.

Represents 11,485 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

Represents 11,485 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .

Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .

Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

Represents 7,657 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.

Represents 50,000 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on December 11, 2025 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments commencing as of the Grant Date.

Represents Ordinary Shares sold in the open market on September 2, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 31, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 31, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Represents stock options granted under the 2025 Incentive Compensation Plan on August 13, 2025. The option shall vest and become exercisable in four equal annual installments beginning on August 13, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

Represents 71,839 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

The shares underlying this option shall vest in four equal annual installments beginning on June 2, 2026, subject to the Reporting Person's continued service as of each such vesting date.

Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $2.67 to $2.72. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $1.67 to $2.66. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $3.065 to $4.06. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $2.90 to $3.06. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Represents Ordinary Shares purchased in the open market on December 13, 2024.

Represents Ordinary Shares sold in the open market on December 13, 2024.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

These securities are held in a family trust for the benefit of the reporting person and her spouse. The reporting person and her spouse are co-trustees of the trust. The reporting person disclaims beneficial ownership of the securities held by the Richner-Russell Family Trust except to the extent of her pecuniary interest therein.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.95 to $2.07. The Reporting Person undertakes to provide Lifeward Ltd. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87. The Reporting Person undertakes to provide Lifeward Ltd. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.80 to $1.85. The Reporting Person undertakes to provide Lifeward Ltd. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Represents Ordinary Shares sold in the open market on September 13, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on September 13, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on September 13, 2023 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.16 to $3.31. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Represents Ordinary Shares sold in the open market on September 3, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 31, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 31, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.23 to $3.35. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Represents Ordinary Shares sold in the open market on August 2, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 2, 2022 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.73 to $4.29. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Represents Ordinary Shares sold in the open market on August 2, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on August 2, 2022 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.73 to $4.29. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Represents Ordinary Shares sold in the open market on July 1, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on June 30, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on June 30, 2023 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.75 to $3.91. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

The reported number of shares has been adjusted to reflect the impact of the Company's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents Ordinary Shares sold in the open market on June 18, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on June 18, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on June 18, 2020 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Represents Ordinary Shares purchased in the open market on May 23, 2024.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents Ordinary Shares purchased in the open market on May 23, 2024.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents Ordinary Shares purchased in the open market on May 22, 2024.

The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents Ordinary Shares sold in the open market on May 21, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

The reported number of shares has been adjusted to reflect the impact of the Company's 1-for-7 reverse share split, which became effective on March 15, 2024.

Represents 10,040 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on April 18, 2024 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments on each of July 18, 2024, October 18, 2024, January 18, 2025 and April 18, 2025.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $0.71 to $0.73. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $0.66 to $0.73. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Reflects securities held directly by Lind Global Macro Fund LP. Lind Global Partners LLC, the general partner of Lind Global Macro Fund LP, and Jeff Easton, the managing member of Lind Global Partners LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

Represents 200,000 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal annual installments, commencing as of the Grant Date.

Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.